🍄 Trial Participants Got a Measured Dose. Mushrooms Don't Come Labeled. Psilocybin content can vary between species, batches, and even parts of the same mushroom. What you buy isn't always what you get—estimate potency before you assume.
🧪 Microdosing Starts With Knowing What's on the Tab Study participants knew exactly what they took and how much. Your tab doesn't come with that guarantee. What you buy isn't always what you get—test it first.
🧪 Is Your Tab LSD, 1P-LSD, or Something Else? Blotter art and seller descriptions can't tell you what's on a tab. Cross-testing with multiple reagents gives you far more information than any label or single reaction.
🧪 Know What's Really in Your Cocaine What you buy isn't always what you get. Screen for fentanyl with test strips, cross-check with reagents, and know more about what's in your bag before you use it.
🧪 Clinical LSD Is Measured. Street LSD Isn't. Trial participants know exactly what they're taking and how much. A tab from outside a study comes with no such guarantee. Screen for identity with reagents before you ever think about dose.
🧪 Research Uses Verified LSD. Does Your Tab Come With That Guarantee? Every study starts with a known compound and a known dose. Outside the lab, artwork and a seller's word tell you nothing. Reagent testing is the most accessible way to screen your tab before you take it.
New research suggests that psychedelics may be capable of more than altering consciousness; they might also play a role in calming inflammation and balancing the immune system. Scientists studying compounds like LSD, psilocybin, and DMT are finding that these molecules interact with immune pathways in ways that could reshape how we treat...
A groundbreaking phase two clinical trial has found that a single 100-microgram (ug) dose of LSD, in its pharmaceutical formulation MM120, can significantly reduce symptoms of generalized anxiety disorder (GAD). What makes this finding especially noteworthy is that the relief lasted for up to twelve weeks after just one dose. The results were striking. Nearly...
DMT is known for producing short, powerful psychedelic experiences, but new research suggests its potential goes far beyond the trip. Scientists are now exploring how low, non-hallucinogenic doses of DMT could help heal the brain after a stroke. In this post, we’ll break down what the latest study found, what it means for the future...
Germany has taken a historic step by permitting psychiatrists to prescribe psilocybin for treatment‑resistant depression under a compassionate‑use framework. This marks the first time a European Union country has given doctors authority to administer the psychedelic compound outside of clinical trials. The Central Institute of Mental Health (CIMH) in Mannheim and Berlin’s OVID Clinic, both...
